Allied Market Research
Upcoming Allied Market Research
Hemostat Market

Hemostat Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

Pages: NA
Dec 2021 | 266 Views
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Hemostat Market

Request Now !

The hemostats are those enzymes that can be used in stopping the bleeding during peri-operative procedures. Topical hemostats are used intraoperatively primarily and postoperatively to a lesser extent. The agents can be used in order to diffuse oozing venous type bleeds, raw surface bleeding, bone bleeding, and also needle-hole bleeding. The surgical bleeding adds various numbers of complications to the patient, which include, altered vision in the surgical field, unstable hemodynamics, amplified need for blood transfusions, higher operative time, greater risk of infection, amplified cost, and also increased overall mortality. Based on the severity of the bleeding and the coagulation status of the patient, these hemostats are used.

Market scope and structure analysis:

Report Metric


  Market size available for years


  Base year considered


  Forecast period


  Forecast units

  Value (USD)

  Segments covered

  Product, Application, Formulation and Region

  Regions covered

North America (U.S. and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa

  Companies covered

Major players analyzed include CR Bard, Inc., B. Braun Melsungen AG, Baxter International, Inc., Integra LifeSciences, Marine Polymer Technologies, Inc., Teleflex, Ethicon, Inc., Pfizer, Inc., Z-Medica LLC, Gelita Medical GmbH

COVID-19 scenario analysis:

The coronavisur-2 posed challenges for healthcare professionals worldwide, as the medications were not available during the initial stages. The government forced the population to be locked out, which caused the global economic recession. The COVID-19 pandemic has negatively impact on the healthcare system, causing 50% to 70% drop in revenue from March. There are many small hospitals, clinics and nursing homes, have been forced to shut their operations. As a result, of the stipulated social distancing and the localized curfews had resulted in delayed elective surgical procedures. Additionally, visa cancellations have led to a break in medical tourism and can harmfully impact the healthcare services market growth.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The major factors which are used to propel the market include rising number of surgical procedures, growth in the number of regulatory approvals, surge in incidences of sports-related injuries and spinal implants. The increase in the focus on effective blood loss management in patients during the surgeries would help the industry in the forecast period. However, the stringent regulatory framework may hinder the market growth in the commenced period.

New product advancements to flourish the market

In March 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, had announced the strategic regional launch of SURGICEL POWDER ABSORBABLE HEMOSTAT. This innovation is a powdered adjunctive hemostat that is designed to aid surgeons control disruptive bleeding more competently. Disruptive bleeding occurs in more than 60% of open surgical procedures, which increases the health care costs and is associated with high mortality rates.

In December 2018, Baxter International Inc., which is a global leader in advancing surgical innovation, announced the introduction of Disposable Curved Applicator, which enhances the delivery experience of its Floseal Hemostatic Matrix product line for procedures in the otolaryngology, head and neck surgical specialty (often referred to as ENT).

Surge in mergers and acquisitions to boost the market

In August 2013, C. R. Bard, Inc. announced that it has entered into a definitive agreement to acquire privately-held Medafor, Inc., which is a leading developer and supplier of plant based hemostatic agents for the purchase price of $200 million paid at closing, anticipated to occur later that year, and future contingent payments up to an additional $80 million based on specific revenue-based milestones. The transaction is structured as a merger and has been approved by both companies’ boards of directors, and is subject to an approval by Medafor’s shareholders and customary regulatory review.

In March 2018, Baxter closed the $153 million acquisition of hemostat and sealant assets from Mallinckrodt Pharmaceuticals. Baxter announced in January its plan to acquire the stand-alone recombinant thrombin Recothrom and Preveleak surgical sealant for vascular reconstruction.

Key segments covered:




  • Thrombin-based hemostats
  • Combination hemostats
  • Gelatin-based hemostats
  • Collagen-based hemostats
  • Others


  • Orthopedic surgery
  • General surgery
  • Neurological surgery
  • Cardiovascular surgery
  • Gynecological surgery
  • Others


  • Matrix & gel hemostats
  • Sheet & pad hemostats
  • Sponge hemostats
  • Powder hemostats


Key benefits of the report:

  • This study presents the analytical depiction of the global Hemostat industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Hemostat market share.
  • The current market is quantitatively analyzed from 2020 to 2027 to highlight the global Hemostat market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Hemostat market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Hemostat Market research report:

  • What are the leading market players active in the Hemostat market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in tasking further strategic steps?
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

Toll-free :
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email :
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.










Purchase Full Report of
Hemostat Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise

  • $9,995  $8,996
  • Unlimited
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers


Featured Reports


Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings


Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers